Key result
Screening CCTA detects elevated coronary inflammation in ~43% of asymptomatic adults, independent of clinical risk.
Why the study?
The coronary perivascular fat attenuation index score (FAI-Score) on CCTA quantifies vascular inflammation and predicts cardiac mortality in symptomatic cohorts, but its prevalence, anatomical distribution, and clinical correlates in asymptomatic primary prevention populations remained uncharacterized.
What is the prevalence, anatomical distribution, and clinical/biomarker correlates of CCTA-derived coronary perivascular inflammation (FAI-Score) in an asymptomatic adult primary prevention population?
Cross-Sectional (n=84)
Yes
What is the prevalence, anatomical distribution, and clinical/biomarker correlates of CCTA-derived coronary perivascular inflammation (FAI-Score) in an asymptomatic adult primary prevention population?
Coronary perivascular inflammation quantified by CCTA FAI-Score is prevalent in asymptomatic primary prevention adults and frequently occurs in the absence of coronary plaque, luminal stenosis, or elevated traditional cardiovascular biomarkers.
Elevated FAI-Score occurs frequently in asymptomatic adults independent of biomarkers; hypothesis-generating and should not yet change practice.
Background Coronary perivascular fat attenuation index score (FAI-Score) on coronary computed tomography angiography (CCTA) quantifies vascular inflammation and predicts cardiac mortality in symptomatic cohorts. However, its prevalence, anatomical distribution, and clinical correlates in asymptomatic primary prevention populations remain uncharacterized. Methods In an IRB-approved prospective study across two clinical sites, 84 consecutive asymptomatic adults (mean age 53.7 ± 8.6 years; 63.1% men) with no prior coronary artery disease underwent screening CCTA and comprehensive clinical, metabolic, and biomarker profiling. AI-standardized FAI-Score was quantified across three epicardial vessels (LAD, LCx, RCA). High and very high perivascular inflammation were pre-specified as any vessel ≥75th and ≥90th percentiles, respectively. Luminal stenosis and plaque were graded using CAD-RADS 2.0. Results Elevated FAI-Score (≥75th percentile) was present in 42.9% of participants (36/84; 95% CI 32.8% - 53.5%), with 17.9% (15/84; 95% CI 11.1% - 27.4%) exhibiting very high inflammation (≥90th percentile). Multi-vessel inflammation was identified in 17.9% (15/84), with the RCA most frequently involved (≥90th percentile in 13.1%). Standard circulating biomarkers, including ApoB, non-HDL-C, HbA1c, and PREVENT-ASCVD 10-year risk showed no association with binary inflammation. Systemic hs-CRP (median 0.8 mg/L) exhibited an inverse correlation with maximum vessel FAI-Score (Spearman ρ=−0.27, p=0.014). Men demonstrated higher rates of elevated FAI-Score than women (52.8% vs. 25.8%, p=0.016; ≥90th percentile: 26.4% vs. 3.2%, p=0.007). Strikingly, 46.2% (30/65) of participants with normal luminal anatomy (CAD-RADS 0) and 47.2% (25/53) with zero plaque burden harbored elevated FAI-Score; all 15 individuals with very high FAI-Score had CAD-RADS 0 (Fisher’s exact p=0.018). Body mass index was the sole secondary correlate surviving false discovery rate correction (AUC = 0.71, p=0.001, all-test FDR q=0.028). Regularized multivariable models showed modest out-of-sample discrimination for FAI-Score elevation (cross-validated AUC = 0.71). Conclusions Coronary perivascular inflammation is common among asymptomatic adults and frequently uncouples from structural plaque and luminal stenosis. Routine circulating biomarkers and clinical risk calculators fail to identify inflamed vessels, highlighting FAI-Score as an independent dimension of primary cardiovascular risk assessment.
No takes yet. Share an insight, caveat, or question.
Stan et al. (2026) conducted a cross-sectional in Coronary perivascular inflammation in asymptomatic primary prevention (n=84). Screening CCTA with AI-standardized Fat Attenuation Index Score (FAI-Score) and clinical biomarker profiling was evaluated on Prevalence of elevated perivascular inflammation (FAI-Score ≥75th percentile in any epicardial vessel) (95% CI 32.8% - 53.5%). Screening CCTA identified elevated coronary FAI-Score (≥75th percentile) in 42.9% of asymptomatic adults (95% CI 32.8%-53.5%), showing no association with routine lipid biomarkers or clinical risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: